These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 34322403)

  • 21. Efficacy and Safety of Anti-malarial Drugs (Chloroquine and Hydroxy-Chloroquine) in Treatment of COVID-19 Infection: A Systematic Review and Meta-Analysis.
    Das RR; Jaiswal N; Dev N; Jaiswal N; Naik SS; Sankar J
    Front Med (Lausanne); 2020; 7():482. PubMed ID: 32850924
    [No Abstract]   [Full Text] [Related]  

  • 22. Hydroxychloroquine and QTc prolongation in patients with COVID-19: A systematic review and meta-analysis.
    Agstam S; Yadav A; Kumar-M P; Gupta A
    Indian Pacing Electrophysiol J; 2021; 21(1):36-43. PubMed ID: 33075484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of Hydroxychloroquine and Chloroquine Safety Profiles: A Systematic Review and Meta-Analysis.
    Ren L; Xu W; Overton JL; Yu S; Chiamvimonvat N; Thai PN
    medRxiv; 2020 May; ():. PubMed ID: 32511539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients.
    Lammers AJJ; Brohet RM; Theunissen REP; Koster C; Rood R; Verhagen DWM; Brinkman K; Hassing RJ; Dofferhoff A; El Moussaoui R; Hermanides G; Ellerbroek J; Bokhizzou N; Visser H; van den Berge M; Bax H; Postma DF; Groeneveld PHP
    Int J Infect Dis; 2020 Dec; 101():283-289. PubMed ID: 33007454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story.
    Gasmi A; Peana M; Noor S; Lysiuk R; Menzel A; Gasmi Benahmed A; Bjørklund G
    Appl Microbiol Biotechnol; 2021 Feb; 105(4):1333-1343. PubMed ID: 33515285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis.
    Kashour Z; Riaz M; Garbati MA; AlDosary O; Tlayjeh H; Gerberi D; Murad MH; Sohail MR; Kashour T; Tleyjeh IM
    J Antimicrob Chemother; 2021 Jan; 76(1):30-42. PubMed ID: 33031488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Rapid Systematic Review of Clinical Trials Utilizing Chloroquine and Hydroxychloroquine as a Treatment for COVID-19.
    Chowdhury MS; Rathod J; Gernsheimer J
    Acad Emerg Med; 2020 Jun; 27(6):493-504. PubMed ID: 32359203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19.
    Ho TC; Wang YH; Chen YL; Tsai WC; Lee CH; Chuang KP; Chen YA; Yuan CH; Ho SY; Yang MH; Tyan YC
    Pathogens; 2021 Feb; 10(2):. PubMed ID: 33671315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chloroquine and hydroxychloroquine for COVID-19: Perspectives on their failure in repurposing.
    Shah RR
    J Clin Pharm Ther; 2021 Feb; 46(1):17-27. PubMed ID: 32981089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydroxychloroquine/chloroquine in patients with COVID-19 in Wuhan, China: a retrospective cohort study.
    Chen Z; Liu A; Cheng Y; Wang X; Xu X; Huang J; Ma Y; Gao M; Huang C
    BMC Infect Dis; 2021 Aug; 21(1):805. PubMed ID: 34384388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. QT interval and repolarization dispersion changes during the administration of hydroxychloroquine/chloroquine with/without azithromycin in early COVID 19 pandemic: A prospective observational study from two academic hospitals in Indonesia.
    Gumilang RA; Siswanto ; Anggraeni VY; Trisnawati I; Budiono E; Hartopo AB
    J Arrhythm; 2021 Oct; 37(5):1184-1195. PubMed ID: 34621417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 Infection in Rheumatic Patients on Chronic Antimalarial Drugs: A Systematic Review and Meta-Analysis.
    Landsteiner de Sampaio Amêndola I; Aires Pinheiro J; Póvoa P; Cés de Souza Dantas V; Serafim RB
    J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac Toxicity of Chloroquine or Hydroxychloroquine in Patients With COVID-19: A Systematic Review and Meta-regression Analysis.
    Tleyjeh IM; Kashour Z; AlDosary O; Riaz M; Tlayjeh H; Garbati MA; Tleyjeh R; Al-Mallah MH; Sohail MR; Gerberi D; Bin Abdulhak AA; Giudicessi JR; Ackerman MJ; Kashour T
    Mayo Clin Proc Innov Qual Outcomes; 2021 Feb; 5(1):137-150. PubMed ID: 33163895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports.
    Goldman A; Bomze D; Dankner R; Hod H; Meirson T; Boursi B; Maor E
    Br J Clin Pharmacol; 2021 Mar; 87(3):1432-1442. PubMed ID: 32964535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of hydroxychloroquine as pre-and post-exposure prophylaxis and treatment of COVID-19: A systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials.
    Martins-Filho PR; Ferreira LC; Heimfarth L; Araújo AAS; Quintans-Júnior LJ
    Lancet Reg Health Am; 2021 Oct; 2():100062. PubMed ID: 34485970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of azithromycin and hydroxychloroquine in patients hospitalized with COVID-19: Network meta-analysis of randomized controlled trials.
    Chi G; Memar Montazerin S; Lee JJ; Kazmi SHA; Shojaei F; Fitzgerald C; Gibson CM
    J Med Virol; 2021 Dec; 93(12):6737-6749. PubMed ID: 34370328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serious Cardiovascular Adverse Events Associated with Hydroxychloroquine/Chloroquine Alone or with Azithromycin in Patients with COVID-19: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS).
    Zhao Y; Zhang J; Zheng K; Thai S; Simpson RJ; Kinlaw AC; Xu Y; Wei J; Cui X; Buse JB; Stürmer T; Wang T
    Drugs Real World Outcomes; 2022 Jun; 9(2):231-241. PubMed ID: 35386046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virological and clinical cure in COVID-19 patients treated with hydroxychloroquine: A systematic review and meta-analysis.
    Sarma P; Kaur H; Kumar H; Mahendru D; Avti P; Bhattacharyya A; Prajapat M; Shekhar N; Kumar S; Singh R; Singh A; Dhibar DP; Prakash A; Medhi B
    J Med Virol; 2020 Jul; 92(7):776-785. PubMed ID: 32297988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysis.
    Di Stefano L; Ogburn EL; Ram M; Scharfstein DO; Li T; Khanal P; Baksh SN; McBee N; Gruber J; Gildea MR; Clark MR; Goldenberg NA; Bennani Y; Brown SM; Buckel WR; Clement ME; Mulligan MJ; O'Halloran JA; Rauseo AM; Self WH; Semler MW; Seto T; Stout JE; Ulrich RJ; Victory J; Bierer BE; Hanley DF; Freilich D;
    PLoS One; 2022; 17(9):e0273526. PubMed ID: 36173983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic review and meta-analysis of the effectiveness and safety of hydroxychloroquine in treating COVID-19 patients.
    Yang TH; Chou CY; Yang YF; Chien CS; Yarmishyn AA; Yang TY; Liu CH; Chang KJ; Yang YP; Chang YL
    J Chin Med Assoc; 2021 Feb; 84(2):233-241. PubMed ID: 32947506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.